Simoctocog Alfa Effective, Safe in Children With Severe Hemophilia A

Recent studies reveal that simoctocog alfa (Nuwiq) offers effective prophylaxis and treatment for severe hemophilia A in children, with low inhibitor rates and strong long-term safety and efficacy.

Related Keywords

Thromb Haemost , ,Therapeutic Advances ,Image Credit ,